Spruce Biosciences is a United States biopharmaceutical company focused on developing therapies for rare endocrine disorders. The company has concentrated on clinical-stage programs targeting conditions related to adrenal steroid imbalance.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!